Is It Idiopathic Pulmonary Fibrosis or Not?

References

1. 1.↵
   1. Wright WC

   1. Ramazzini B

   . Diseases of workers (Wright WC, trans). New York, NY: Hafner; 1964, 243.
2. 2.↵
   1. Knoll MA,
   2. Salvatore M,
   3. Sheu RD,
   4. et al

   . The use of isodose levels to interpret radiation induced lung injury: A quantitative analysis of computed tomography changes. Quant Imaging Med Surg 2016;6:35–41.

   OpenUrl
3. 3.↵
   1. Salvatore M,
   2. Henschke CI,
   3. Yip R,
   4. et al

   . Osteophyte induced lung fibrosis prevalence and osteophyte qualities predicting disease. Clin Imag 2017;44:1–4.

   OpenUrl
4. 4.↵
   1. Simon M,
   2. Potchen EJ,
   3. LeMay M

   1. Liebow AA,
   2. Carrington CB

   . The interstitial pneumonias. In: Simon M, Potchen EJ, LeMay M, eds. Frontiers of pulmonary radiology. 1st ed. New York, NY: Grune & Stratton; 1969, 102–141.
5. 5.↵
   1. Travis WD,
   2. Costabel U,
   3. Hansell DM,
   4. et al

   . An official American Thoracic Society/European Respiratory Society statement: Update of the international multidisciplinary classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med 2013;188:733–48.

   OpenUrlCrossRefPubMedWeb of Science
6. 6.↵
   1. Nathan SD,
   2. Shlobin OA,
   3. Weir N,
   4. et al

   . Long-term course and prognosis of idiopathic pulmonary fibrosis in the new millennium. Chest 2011;140:221–9.

   OpenUrlCrossRefPubMedWeb of Science
7. 7.↵
   1. Raghu G,
   2. Chen SY,
   3. Yeh WS,
   4. et al

   . Idiopathic pulmonary fibrosis in US Medicare beneficiaries aged 65 years and older: Incidence, prevalence, and survival, 2001–11. Lancet Respir Med 2014;2:566–72.

   OpenUrlCrossRefPubMed
8. 8.↵
   1. Raghu G,
   2. Collard HR,
   3. Egan JJ,
   4. et al

   . An official ATS/ERS/JRS/ALAT statement: Idiopathic pulmonary fibrosis: Evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med 2011;183:788–824.

   OpenUrlCrossRefPubMedWeb of Science
9. 9.↵
   1. King TE Jr.,
   2. Pardo A,
   3. Selman M

   . Idiopathic pulmonary fibrosis. Lancet 2011;378:1949–61.

   OpenUrlCrossRefPubMedWeb of Science
10. 10.↵
    1. Jo HE,
    2. Corte TJ,
    3. Moodley Y,
    4. et al

    . Evaluating the interstitial lung disease multidisciplinary meeting: A survey of expert centres. BMC Pulm Med 2016;16:22.

    OpenUrlCrossRefPubMed
11. 11.↵
    1. Raghu G,
    2. Anstrom KJ,
    3. King TE Jr.,
    4. Lasky JA,
    5. Martinez FJ

    . Prednisone, azathioprine, and N-acetylcysteine for pulmonary fibrosis. N Engl J Med 2012;366:1968–77.

    OpenUrlCrossRefPubMedWeb of Science
12. 12.↵
    1. Raghu G,
    2. Brown KK,
    3. Bradford WZ,
    4. et al

    . A placebo-controlled trial of interferon gamma-1b in patients with idiopathic pulmonary fibrosis. N Engl J Med 2004;350:125–33.

    OpenUrlCrossRefPubMedWeb of Science
13. 13.↵
    1. Noble PW,
    2. Albera C,
    3. Bradford WZ,
    4. et al

    . Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): Two randomised trials. Lancet 2011;377:1760–9.

    OpenUrlCrossRefPubMedWeb of Science
14. 14.↵
    1. Richeldi L,
    2. Costabel U,
    3. Selman M,
    4. et al

    . Efficacy of a tyrosine kinase inhibitor in idiopathic pulmonary fibrosis. N Engl J Med 2011;365:1079–87.

    OpenUrlCrossRefPubMedWeb of Science
15. 15.↵
    1. Richeldi L,
    2. du Bois RM,
    3. Raghu G,
    4. et al

    . Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis. N Engl J Med 2014;370:2071–82.

    OpenUrlCrossRefPubMedWeb of Science
16. 16.↵
    1. Webb WR,
    2. Muller NL,
    3. Naidich DP

    . High resolution CT of the lung. 4th ed. Philadelphia, PA: Lippincott Williams and Wilkins, 2009.
17. 17.↵
    1. Arakawa H,
    2. Honma K

    . Honeycomb lung: History and current concepts. AJR 2011;196:773–82.

    OpenUrlCrossRefPubMed
18. 18.↵
    1. Yamauchi H,
    2. Bando M,
    3. Baba T,
    4. et al

    . Clinical Course and Changes in High-Resolution Computed Tomography Findings in Patients with Idiopathic Pulmonary Fibrosis without Honeycombing. PLoS One 2016;11:e0166168.

    OpenUrl
19. 19.↵
    1. Raghu G,
    2. Wells AU,
    3. Nicholson AG,
    4. et al

    . Effect of nintedanib in subgroups of idiopathic pulmonary fibrosis by diagnostic criteria. Am J Respir Crit Care Med 2017;195:78–85.

    OpenUrl
20. 20.↵
    1. Bjoraker JA,
    2. Ryu JH,
    3. Edwin MK,
    4. et al

    . Prognostic significance of histopathologic subsets in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 1998;157:199–203.

    OpenUrlCrossRefPubMedWeb of Science
21. 21.↵
    1. Nicholson AG,
    2. Colby TV,
    3. du Bois RM,
    4. Hansell DM,
    5. Wells AU

    . The prognostic significance of the histologic pattern of interstitial pneumonia in patients presenting with the clinical entity of cryptogenic fibrosing alveolitis. Am J Respir Crit Care Med 2000;162:2213–7.

    OpenUrlCrossRefPubMedWeb of Science
22. 22.↵
    1. Daniil ZD,
    2. Gilchrist FC,
    3. Nicholson AG,
    4. et al

    . A histologic pattern of nonspecific interstitial pneumonia is associated with a better prognosis than usual interstitial pneumonia in patients with cryptogenic fibrosing alveolitis. Am J Respir Crit Care Med 1999;160:899–905.

    OpenUrlCrossRefPubMedWeb of Science
23. 23.↵
    1. Nagai S,
    2. Kitaichi M,
    3. Itoh H,
    4. Nishimura K,
    5. Izumi T,
    6. Colby TV

    . Idiopathic nonspecific interstitial pneumonia/fibrosis: Comparison with idiopathic pulmonary fibrosis and BOOP. Eur Respir J 1998;12:1010–9.

    OpenUrlAbstract
24. 24.↵
    1. Arakawa H,
    2. Yamada H,
    3. Kurihara Y,
    4. et al

    . Nonspecific interstitial pneumonia associated with polymyositis and dermatomyositis: serial high-resolution CT findings and functional correlation. Chest 2003;123:1096–103.

    OpenUrlCrossRefPubMedWeb of Science
25. 25.↵
    1. Kim DS,
    2. Yoo B,
    3. Lee JS,
    4. et al

    . The major histopathologic pattern of pulmonary fibrosis in scleroderma is nonspecific interstitial pneumonia. Sarcoidosis Vasc Diffuse Lung Dis 2002;9:121–7.

    OpenUrl
26. 26.↵
    1. Yamadori I,
    2. Fujita J,
    3. Bandoh S,
    4. et al

    . Nonspecific interstitial pneumonia as pulmonary involvement of primary Sjögren's syndrome. Rheumatol Int 2002;22:89–92.

    OpenUrlCrossRefPubMedWeb of Science
27. 27.↵
    1. Fischer A,
    2. Antoniou KM,
    3. Brown KK,
    4. et al

    . An official European Respiratory Society/American Thoracic Society research statement: Interstitial pneumonia with autoimmune features. Eur Respir J 2015;46:976–87.

    OpenUrlAbstract/FREE Full Text
28. 28.↵
    1. Belloli EA,
    2. Beckford R,
    3. Hadley R,
    4. Flaherty KR

    . Idiopathic non-specific interstitial pneumonia. Respirology 2016;21:259–68.

    OpenUrl
29. 29.↵
    1. Travis WD,
    2. Hunninghake G,
    3. King TE Jr.,
    4. et al

    . Idiopathic nonspecific interstitial pneumonia: Report of an American Thoracic Society project. Am J Respir Crit Care Med 2008;177:1338–47.

    OpenUrlCrossRefPubMedWeb of Science
30. 30.↵
    1. Park IN,
    2. Jegal Y,
    3. Kim DS,
    4. et al

    . Clinical course and lung function change of idiopathic nonspecific interstitial pneumonia. Eur Respir J 2009;33:68–76.

    OpenUrlAbstract/FREE Full Text
31. 31.↵
    1. Lee JY,
    2. Jin SM,
    3. Lee BJ,
    4. Chung DH,
    5. et al

    . Treatment response and long term follow-up results of nonspecific interstitial pneumonia. J Korean Med Sci 2012;27:661–7.

    OpenUrlCrossRefPubMed
32. 32.↵
    1. Smith ML

    . Update on pulmonary fibrosis: Not all fibrosis is created equally. Arch Pathol Lab Med 2016;140:221–9.

    OpenUrl
33. 33.↵
    1. Johkoh T

    . Nonspecific interstitial pneumonia and usual interstitial pneumonia: Is differentiation possible by high-resolution computed tomography? Semin Ultrasound CT MR 2014;35:24–8.

    OpenUrl
34. 34.↵
    1. Trahan S,
    2. Hanak V,
    3. Ryu JH,
    4. Myers JL

    . Role of surgical lung biopsy in separating chronic hypersensitivity pneumonia from usual interstitial pneumonia/idiopathic pulmonary fibrosis: Analysis of 31 biopsies from 15 patients. Chest 2008;134:126–32.

    OpenUrlCrossRefPubMedWeb of Science
35. 35.↵
    1. Ohtani Y,
    2. Saiki S,
    3. Kitaichi M,
    4. et al

    . Chronic bird fancier's lung: histopathological and clinical correlation. An application of the 2002 ATS/ERS consensus classification of the idiopathic interstitial pneumonias. Thorax 2005;60:665–71.

    OpenUrlAbstract/FREE Full Text
36. 36.↵
    1. Churg A,
    2. Sin DD,
    3. Everett D,
    4. Brown K,
    5. Cool C

    . Pathologic patterns and survival in chronic hypersensitivity pneumonitis. Am J Surg Pathol 2009;33:1765–70.

    OpenUrlCrossRefPubMed
37. 37.↵
    1. Lima MS,
    2. Coletta EN,
    3. Ferreira RG,
    4. et al

    . Subacute and chronic hypersensitivity pneumonitis: Histopathological patterns and survival. Respir Med 2009;103:508–15.

    OpenUrlCrossRefPubMedWeb of Science
38. 38.↵
    1. Gaxiola M,
    2. Buendía-Roldán I,
    3. Mejía M,
    4. et al

    . Morphologic diversity of chronic pigeon breeder's disease: Clinical features and survival. Respir Med 2011;105:608–14.

    OpenUrlCrossRefPubMed
39. 39.↵
    1. Vourlekis JS,
    2. Schwarz MI,
    3. Cool CD,
    4. et al

    . Nonspecific interstitial pneumonitis as the sole histologic expression of hypersensitivity pneumonitis. Am J Med 2002;112:490–3.

    OpenUrlCrossRefPubMedWeb of Science
40. 40.
    1. Salisbury ML,
    2. Myers JL,
    3. Belloli EA,
    4. Kazerooni EA,
    5. Martinez FJ,
    6. Flaherty KR

    . Diagnosis and treatment of fibrotic hypersensitivity pneumonia. Where we stand and where we need to go. Am J Respir Crit Care Med. 2017;196:690–9.

    OpenUrl
41. 41.↵
    1. Torres PP,
    2. Moreira MA,
    3. Silva DG,
    4. da Gama RR,
    5. Sugita DM,
    6. Moreira MA

    . High-resolution computed tomography and histopathological findings in hypersensitivity pneumonitis: A pictorial essay. Radiol Bras 2016;49:112–6.

    OpenUrl
42. 42.↵
    1. Park WH,
    2. Kim SS,
    3. Shim SC,
    4. et al

    . Visual Assessment of chest computed tomography findings in anti-cyclic citrullinated peptide antibody positive rheumatoid arthritis: Is it associated with airway abnormalities? Lung 2016;194:97–105.

    OpenUrl
43. 43.↵
    1. Rybicki BA,
    2. Major M,
    3. Popovich J Jr.,
    4. et al

    . Racial differences in sarcoidosis incidence: A 5-year study in a health maintenance organization. Am J Epidemiol 1997;145:234–241.

    OpenUrlCrossRefPubMedWeb of Science
44. 44.↵
    1. Baughman RP,
    2. Teirstein AS,
    3. Judson MA,
    4. et al

    . Clinical characteristics of patients in a case control study of sarcoidosis. Am J Respir Crit Care Med 2001;164(10 Pt 1):1885–9.

    OpenUrlCrossRefPubMedWeb of Science
45. 45.↵
    1. Patterson KC,
    2. Strek ME

    . Pulmonary fibrosis in sarcoidosis. Clinical features and outcomes. Ann Am Thorac Soc 2013;10:362–70.

    OpenUrlCrossRefPubMed
46. 46.↵
    1. Ramachandraiah V,
    2. Aronow W,
    3. Chandy D

    . Pulmonary sarcoidosis: An update. Postgrad Med 2017;129:149–158.

    OpenUrl
47. 47.↵
    1. Nunes H,
    2. Humbert M,
    3. Capron F,
    4. et al

    . Pulmonary hypertension associated with sarcoidosis: Mechanisms, haemodynamics and prognosis. Thorax 2006;61:68–74.

    OpenUrlAbstract/FREE Full Text
48. 48.↵
    1. Teirstein AT,
    2. Morgenthau AS

    . “End-stage” pulmonary fibrosis in sarcoidosis. Mt Sinai J Med 2009;76:30–6.

    OpenUrlCrossRefPubMed
49. 49.↵
    1. Hansell DM,
    2. Milne DG,
    3. Wilsher ML,
    4. Wells AU

    . Pulmonary sarcoidosis: morphologic associations of airflow obstruction at thin-section CT. Radiology 1998;209:697–704.

    OpenUrlCrossRefPubMedWeb of Science
50. 50.↵
    1. Criado E,
    2. Sánchez M,
    3. Ramírez J,
    4. et al

    . Pulmonary sarcoidosis: typical and atypical manifestations at high-resolution CT with pathologic correlation. Radiographics 2010;30:1567–86.

    OpenUrlCrossRefPubMedWeb of Science
51. 51.↵
    1. Pollack A

    . F.D.A. approves first 2 drugs for treatment of a fatal lung disease. NY Times. October 14, 2014.